PMID: 2503957May 1, 1989Paper

The detection of Bacillus anthracis protective antigens by enzyme immunoassay (EIA) using polyclonal and monoclonal antibodies

Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B
C Kleine-Albers, R Böhm

Abstract

An Enzyme-Immunoassay (EIA) for the detection of Bacillus anthracis-protective antigen (PA) within one hour was developed. If the rabbit antiserum was used, 15 ng PA/ml could be detected and with the monoclonal antibody, the detection limit was 60 ng PA/ml. With respect to the higher specificity and with regard to the aspects of animalcare, monoclonal antibodies should be used in the test instead of the polyclonal antiserum.

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.